Completed, Early positive outcome	0
Completed, Positive outcome/primary endpoint(s) met	0
Terminated, Lack of efficacy	1
Completed, Negative outcome/primary endpoint(s) not met	1
Terminated, Safety/adverse effects	2
Terminated, Poor enrollment	3
Completed, Outcome indeterminate	-1
Completed, Outcome unknown	-1
Terminated, Business decision - Drug strategy shift	-1
Terminated, Business decision - Other	-1
Terminated, Business decision - Pipeline reprioritization	-1
Terminated, Lack of funding	-1
Terminated, Other	-1
Terminated, Planned but never initiated	-1
Terminated, Unknown	-1